Press release

DSM delivers very strong Q2 results as transformation progresses

Heerlen, NL, 03 Aug 2010 08:15 CEST

  • Q2 operating profit from continuing operations €246 million (versus €85 million in Q2 2009 and €194 million in Q1 2010)
  • Sales growth from continuing operations 28% compared to Q2 2009
  • Excellent Nutrition performance drives Life Sciences results
  • Materials Sciences continues profit improvement
  • Cash flow from operating activities in Q2 €223 million
  • Interim dividend unchanged at €0.40 per ordinary share
  • Based on current positive business environment, 2010 is expected to be a strong year for DSM

Commenting on the results, Feike Sijbesma, Chairman of the DSM Managing Board, said: “I am delighted to report a very strong second quarter. Operating profit increased by more than 25% compared to the first quarter and for the current business portfolio it was the best quarter in DSM’s history. Our outstanding performance in the quarter reflects very good volumes across our businesses combined with a continued disciplined focus on pricing and costs.

DSM has emerged from the recession as a stronger company and is now reaping the benefits, evidenced by robust results and a very strong balance sheet. DSM is staying the course – fully committed to customers, innovation and sustainability – and continues its transformation towards a Life Sciences and Materials Sciences company. DSM remains vigilant about the broader macro economic developments. Based on the current positive business environment we expect 2010 to be a strong year for DSM.”

Key figures

Q2
2010
Q2
2009
+/- in €
million
H1
2010
H1
2009
+/-
      Continuing operations      
2,268 1,772 28% Net sales 4,331 3,442 26%
354 186 90% Operating profit before depreciation
& amortization (EBITDA)
655 325 102%
246 85 189% Operating profit (EBIT) 440 127 246%
158 124   Nutrition 296 265  
0 3   Pharma 1 14  
58 17   Performance Materials 101 0  
54 4   Polymer Intermediates 97 -26  
22 -10   Base Chemicals and Materials 38 -27  
-46 -53   Other activities -93 -99  
      Discontinued operations:      
138 182   Net sales 305 349  
7 6   Operating profit before depreciation
& amortization (EBITDA)
41 34  
6 -6   Operating profit (EBIT) 30 9  
      Total DSM:      
2,406 1,954 23% Net sales 4,636 3,791 22%
252 79 219% Operating profit (EBIT) 470 136 246%
158 30   Net profit before exceptional items 302 55  
-9 -20   Net result from exceptional items -23 -32  
149 10   Net profit 279 23  
      Net earnings per ordinary share in €:      
0.94 0.22   before exceptional items,
continuing operations
1.70 0.28  
0.90 0.05   including exceptional items,
total DSM
1.68 0.11  

You can find the press release in full, including financial statements, below.

For more information

Lieke de Jong-Tops

Senior Communications Manager
+31 45 578 2420
media.contacts@dsm.com

Dave Huizing

Vice President Investor Relations
+31 45 578 2864
investor.relations@dsm.com

Media Relations

+31 45 578 2420

Investor Relations

+31 45 578 2864

This site uses cookies to store information on your computer.

Learn more